Lyell Immunopharma Inc. (LYEL)
0.48
0.02 (4.35%)
At close: Apr 23, 2025, 10:07 AM
Lyell Immunopharma Revenue
Lyell Immunopharma reported an annual revenue of $61K, reflecting a -53.08% growth. For the quarter ending December 31, 2024, Lyell Immunopharma generated $11K in revenue.
Revenue (ttm)
$61K
Revenue Growth
-53.08%
Price / Sales Ratio
2743.4
Revenue / Employee
$203.33
Employees
300
Market Cap
141.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 61K | -53.08% |
| Dec 31, 2023 | 130K | -99.85% |
| Dec 31, 2022 | 84.68M | +695.15% |
| Dec 31, 2021 | 10.65M | +37.31% |
| Dec 31, 2020 | 7.76M | n/a |